Alpha-methyl-p-tyrosine (AMT) in schizophrenia.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D001794:Blood Pressure; D002395:Catecholamines / Q000652:urine; D004837:Epinephrine / Q000652:urine; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D008333:Mandelic Acids; D008781:Methyltyrosines / Q000627:therapeutic use*; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009069:Movement Disorders / Q000139:chemically induced; D009638:Norepinephrine / Q000652:urine; D010259:Paranoid Disorders / Q000188:drug therapy; D011600:Psychopharmacology; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D002395:Catecholamines; D008333:Mandelic Acids; D008781:Methyltyrosines; D014149:Tranquilizing Agents; D006899:Mixed Function Oxygenases; D009638:Norepinephrine; D004837:Epinephrine